by Robert S. Miller. Dr. Gabriel Hortobagyi discusses the 2011 update of the ASCO guideline on the use of bone-modifying agents in patients with metastatic breast cancer.
Want to check another podcast?
Enter the RSS feed of a podcast, and see all of their public statistics.
This website doesn't track the visitors or use any cookies. Made by Alex Barredo. Send your feedback to alex@barredo.es.
